Copyright © 2019. Inderes Oy. All rights reserved.
Biohit
2761 investors follow this company
The company is not covered. See all listed companies from here.
BUY 2.34 LOWEST 2.34 VOLUME 6 489
SELL 2.36 HIGHEST 2.40 VALUE 0,016 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Upcoming events

12
Aug
Osavuosikatsaukset

Latest insider trading

Net impact profile

Type: stock_exchange_release
4.6.
2020

Biohit Oyj Stock Exchange Release

The coronavirus (2019-nCoV) has impacted negatively on the demand of the company's products globally and due to that Biohit Group's Net Sales outlook for 2020 has changed.

Biohit's new outlook for 2020:

Biohit expects the 2020 Net Sales to decrease in comparison with 2019 (previous year EUR 10.1 million).

Biohit's previous outlook for 2020:

Biohit expects the 2020 Net Sales to increase in comparison with 2019 (previous year EUR 10.1 million).

Type: stock_exchange_release
27.3.
2020

Biohit Oyj Correction
This is a correction to Biohit Oyj's stock exchange release issued on March 27, 2020 at 5:37 p.m. The renumeration policy was incorrectly mentioned in the stock exchange release issued previously. The company has not published the renumeration policy yet.

Biohit Oyj Annual Financial Report

Type: stock_exchange_release
27.3.
2020

Biohit Oyj Correction

Biohit takes the threat of the Corona virus extremely seriously. Based on the development of the Corona virus situation and the policy of the Finnish Government Biohit has decided to convene the Annual General Meeting at a later stage, when the Corona virus does not cause any risks for the health of the participants.  

Helsinki, 27 March 2020

Biohit Oyj
Board of Directors

Type: stock_exchange_release
27.3.
2020

Biohit Oyj Annual Financial Report and Renumeration Policy 

Biohit Oyj's Annual Report 2019 is published today in PDF format. The annual report contains financial statements for 2019, the Report of the Board of Directors and Corporate Governance Statements.Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website:

https://www.biohithealthcare.com/en/investors/annual-reports/

Type: stock_exchange_release
27.3.
2020

Biohit Oyj 

Stock Exchange Release 

 

Biohit takes the threat of the Corona virus extremely seriously as a company which promotes healthy of the people. Biohit has, based on the development of the situation and the announcement by the Finnish Government decided to convene the Annual General Meeting at a later stage when Corona virus does not anymore cause any healthyrisks for for the meeting participants.  

Helsinki, 27 March 2020

Biohit Oyj
Board of Directors

Additional information:

Type: stock_exchange_release
19.2.
2020

Biohit Oyj Financial Statement Release 

SUMMARY

Type: stock_exchange_release
31.1.
2020

 

Notifying Person

Name: Euroclone SpA

Position: Closely associated person

(X) Legal Person

(1): Associated Person

Name: Aiolfi, Franco

Position: Member of the Board

Issuer name: Biohit Plc

LEI: 74370089ATTSNBXJVT29

Notification Type: INITIAL NOTIFICATION

Notification reference: 74370089ATTSNBXJVT29_20200131170019_3

____________________________________________

Transaction date: 2020-01-28

Transaction place not applicable

Instrument: SHARE

ISIN: FI0009005482

Nature of transaction: OTHER

Type: stock_exchange_release
29.11.
2019
 
  • Biohit Oyj will release its financial statements for 2019 on Wednesday 19[th] of February 2020 at 9:30 am.  

  • The Annual Report, which contains the Financial Statements for 2019 and the Report of the Board of Directors, will be published approximately during week 13.

 
  • Biohit Oyj's Annual General Meeting has been planned for Wednesday 22[th] of April 2020 at 5:00 pm. The Board of Directors will call the General Meeting at a later date.

Type: stock_exchange_release
14.10.
2019

Press release
14.10.2019 at 16.15 local time (EEST)

The Ministry of Health of the Russian Federation's recommendation for early detection of gastrointestinal diseases is published in the Journal of Gastroenterology, Hepatology, Coloproctology. This official recommendation, published by three members of the Russian Academy of Sciences representing the Russian Gastroenterology and Oncology Organizations, describes in detail the research and treatment practices that require early detection of gastrointestinal diseases throughout the Russian Federation (1).

Type: stock_exchange_release
14.8.
2019

Biohit Oyj Half Year Financial Report 14 August 2019 at 9:30 am local time (EET)

SUMMARY

January-June 2019

Biohit

English translation unavailable for Biohit.
Biohit